Results from This Site: 61 - 68 of 68 total results for GlaxoSmithKline
  • sell its portfolio of new HIV drugs in development to GlaxoSmithKline for a total of up to $2.9bn (depending on performance). That arrangement doesn't include drugs already launched. Another fertile
  • to crack the well-established lead of Colgate and GlaxoSmithKline in toothpaste. Crest was tested in the UK in the 2000s, but achieved only limited impact. However, Oral B is the leading toothbrush brand
  • account of pharmaceutical and consumer healthcare giant GlaxoSmithKline. more here 18 Arena is the second-string network within Havas, managing regional conflict accounts and a few key international
  • AstraZeneca, Aventis, Bristol Myers-Squibb, GlaxoSmithkline and Johnson & Johnson. Management Matt Giegerich, previously president and CEO of CommonHealth, retained that role in the enlarged Ogilvy
  • Developed originally by GlaxoSmithkline, Asacol was marketed by P&G in the US from 1990, and the company took control of marketing in the UK as well in 2002. In 1997 P&G formed a global pharmaceutical
  • Bids were received from GlaxoSmithKline, Bayer and Novartis, but the eventual buyer was Reckitt Benckiser, with an offer of £1.9bn. Financials Alliance Boots showed a welcome return to form as a privately
  • The split was prompted in part by GlaxoSmithKline's recent acquisition of the vaccines previously controlled by Novartis, which has allowed it to leapfrog both its rivals and become the new global #1.
  • soon-to-be-demerged GSK Consumer Health division of GlaxoSmithKline. Brian McNamara will continue as CEO of the business which is set to separate from its current parent in July 2022. 20th Dec 2021:

All rights reserved © Mind Advertising Ltd 1998-2019